Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy

Neurology

Volumn 63, Issue 2, 2004, Pages 234-240

  Remes, A M ^a   Finnila S ^a   Mononen, H ^a   Tuominen, H ^a   Takalo, R ^a   Herva, R ^a   Majamaa, K ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; COMPLEMENTARY DNA; CYSTATIN C; FLUORODEOXYGLUCOSE F 18; GELSOLIN; GENOMIC DNA; PREALBUMIN; PRESENILIN 1; PRESENILIN 2; RNA;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN BIOPSY; BRAIN WEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; GENETIC DISORDER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTILLATION CAMERA; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULAR AMYLOIDOSIS;

EID: 3242808900     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000129988.68657.FA     Document Type: Article

References (40)

1. Greenberg SM. Cerebral amyloid angiopathy. Prospects for clinical diagnosis and treatment. Neurology 1998;51:690-694.
2. Glenner G, Henry JH, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1998;1:120-129.
3. Hardy J, Seloke DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapies. Science 2002;297:353-356.
4. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
5. Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 2002;109:813-836.
6. Nochlin D, Bird TD, Nemens EJ, Ball MJ, Sumi SM. Amyloid angiopathy in a Volga German family with Alzheimer's disease and presenilin-2 mutation (N141I). Ann Neurol 1998;43:131-135.
7. Revesz T, Holton JL, Lashley T, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002;12:343-357.
8. Levy E, Carman MD, Fernandez-Madrid I, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126.
9. Van Broeckhoven C, Haan J, Bakker E, et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science 1990;248:1124-1126.
10. Bornebroek M, Haan J, Maat-Schieman ML, van Duinen SG, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I. A review of clinical, radiologic and genetic aspects. Brain Pathol 1996;6:111-114.
11. Natte R, Maat-Schieman MLC, Haan J, et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann Neurol 2001;50:765-772.
12. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1992;1:218-221.
13. Miravalle L, Tokuda T, Chiarle R, et al. Substitutions at codon 22 of Alzheimer's A(beta) peptide induce conformational changes and diverse apoptotic effects in human cerebral endothelial cells. J Biol Chem 2000;275:27110-27116.
14. Grabowski TJ, Cho HS, Vonsattel JPG, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001;49:697-705.
15. Greenberg SM, Shin Y, Grabowski TJ, et al. Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology 2003;60:1020-1022.
16. Kamino K, Orr HT, Payami H, Wijsman EM. Lineage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992;51:998-1014.
17. Palsdottir A, Abrahamson M, Thorsteinson L, et al. Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 1988;2:603-604.
18. Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine protease. J Exp Med 1989;169:1771-1778.
19. Vidal R, Frangione B, Rostagno A, et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 1999;399:776-781.
20. Vidal R, Revesz T, Rostagno A, et al. A decamer duplication in the 3′region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 2000;97:4920-4925.
21. Plant GT, Revesz T, Barnard RO, Harding AE, Gautier-Smith PC. Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 1990;113:721-741.
22. Mead S, James-Galton M, Revesz T, et al. Familial British dementia with amyloid angiopathy. Early clinical, neuropsychological and imaging findings. Brain 2000;123:957-991.
23. Holton JL, Lashley T, Braendgaard H, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 2002;61:254-267.
24. Vidal R, Garzuly F, Budka H, et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 1996;148:361-366.
25. Hund E, Linke RP, Willig R, Grau A. Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology 2001;56:431-435.
26. Kiuru S. Gelsolin-related familial amyloidosis Finnish type (FAF), and its variant found worldwide. Amyloid 1998;5:55-66.
27. Wechsler D. WAIS-R manual. New York: Psychological Corp., 1981.
28. Wechsler D. A standardized memory scale for clinical use. J Psychol 1945;19:87-95.
29. Christensen AL. Luria's neuropsychological investigation. Text, Copenhagen: Munksgaard, 1975.
30. Cronholm B, Ottosson N. Reliability and validity of a memory test battery. Acta Psychiatr Scand 1963;39:218-234.
31. Benton AL. The Revised Visual Retention Test. 4th ed. New York: Psychological Corp., 1974.
32. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
33. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993;177:132-144.
34. Joutel A, Andreux F, Gaulis S, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000;105:597-605.
35. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
36. Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
37. Dermaut B, Kumar-Singh S, De Jonghe C, et al. Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain 2001;124:2383-2392.
38. Mandybur IT. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 1986;45:79-90.
39. Vinters HV, Natté R, Maat-Schieman MLC, et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol 1998;95:235-244.
40. Eng JA, Frosch MP, Kyungchan C, Rebeck W, Greenberg SM. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004;55:250-259.